“CLINICAL EVALUATION OF VELAI KUDINEER FOR SUZHI MANTHAM (CHILDHOOD ASTHMA) IN CHILDRENâ€
Phase 2
Recruiting
- Conditions
- FeverWheezing
- Registration Number
- CTRI/2016/05/006972
- Lead Sponsor
- National Institute of Siddha
- Brief Summary
The trial drug “VELAI KUDINEER†is given for 5 days. it contains Velai ver(Cleome viscosa) , Chukku(Zingiber officinale), Venthayam(Trigonella foenum graecum), Vellai poondu(Allium sativum), Vatathiruppi(Sida acuta), Vasambu(Acorus calamus), Oomam(Carum copticum ). drug is given for 5 days b.d. 10 ml given orally.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
wheezing intermittent fever.
Exclusion Criteria
Pneumonia primary complex.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relieving from the symptoms 5 days
- Secondary Outcome Measures
Name Time Method therapeutic efficacy of the trial drugs 1 month
Trial Locations
- Locations (1)
National Institute of Siddha
🇮🇳Chennai, TAMIL NADU, India
National Institute of Siddha🇮🇳Chennai, TAMIL NADU, IndiaDrSKowsalyaPrincipal investigator9698906214saikowsi27@gmail.com